title: COX-2, another important player in the nitric oxide-endothelin cross-talk: good news for COX-2 inhibitors?
authors.forename: Ulrich
authors.initials: U
authors.lastname: Hink
authors.forename: Thomas
authors.initials: T
authors.lastname: Münzel
mesh_terms: D000818:Animals; D051546:Cyclooxygenase 2 / Q000502:physiology*; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D019332:Endothelin-1 / Q000737:chemistry / Q000494:pharmacology; D016232:Endothelins / Q000502:physiology*; D006801:Humans; D009569:Nitric Oxide / Q000172:deficiency / Q000502:physiology*; D010446:Peptide Fragments / Q000494:pharmacology; D044022:Receptor, Endothelin A / Q000819:agonists; D014661:Vasoconstriction / Q000187:drug effects / Q000502:physiology
chemical_list: D016861:Cyclooxygenase Inhibitors; D019332:Endothelin-1; D016232:Endothelins; D010446:Peptide Fragments; D044022:Receptor, Endothelin A; D009569:Nitric Oxide; D051546:Cyclooxygenase 2